Historical record - last NADAC publication: 5/18/2016

Product Information

PROTONIX IV 40 MG VIAL is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $3.7944 per EA under NDC 00008092355. Its NADAC has been published 105 times since Jun 17, 2015.

The High Outlier badge above means this manufacturer's average price in the PANTOPRAZOLE SODIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PROTONIX IV 40 MG VIAL

PANTOPRAZOLE SODIUM
$3.7944per EA
High Outlier

Strength

40 mg/10mL

NDC

00008092355

Classification

Brand

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route

INTRAVENOUS

Last Updated

5/18/2016

Active Ingredients

PANTOPRAZOLE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA020988

On Market Since

5/1/2001

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for PROTONIX IV 40 MG VIAL has been published 105 times since Jun 17, 2015, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.

Current price$3.7944 per EA
All-time high$4.6192 (May 11, 2016)
All-time low$3.7944 (May 18, 2016)
Median price$3.7944
Average price$4.1715
Largest weekly change-17.9% (May 18, 2016)
Weeks tracked105
Tracking sinceJun 17, 2015

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-17.9%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PROTONIX IV 40 MG VIAL?

The current National Average Drug Acquisition Cost (NADAC) for PROTONIX IV 40 MG VIAL, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $3.7944 per EA (NDC 00008092355), effective Jun 14, 2017.

How has the price of PROTONIX IV 40 MG VIAL changed over time?

Over the history we have for it, the NADAC for PROTONIX IV 40 MG VIAL has declined 17.9%. It has been tracked across 105 weekly CMS publications since Jun 17, 2015.

What are the highest and lowest recorded NADAC prices for PROTONIX IV 40 MG VIAL?

Since Jun 17, 2015, the NADAC for PROTONIX IV 40 MG VIAL has ranged from a low of $3.7944 (May 18, 2016) to a high of $4.6192 (May 11, 2016), with a median of $3.7944 per EA.

Are there cheaper alternatives to PROTONIX IV 40 MG VIAL?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PANTOPRAZOLE SOD DR 40 MG TAB, is $0.0361 per EA — about 99% below PROTONIX IV 40 MG VIAL.

Who manufactures PROTONIX IV 40 MG VIAL?

PROTONIX IV 40 MG VIAL (NDC 00008092355) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.